Interesting facts
Interesting Facts about 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid
This compound presents a fascinating structure and applications in the realm of chemistry and pharmaceuticals. Here are some notable points:
- Complex Structure: The compound features a unique molecular architecture comprising multiple functional groups. The presence of a trifluoromethyl group enhances its biological activity and stability.
- Biological Relevance: Compounds with benzothiazole moieties are of great interest due to their diverse biological activities. This particular structure may exhibit potential as a pharmaceutical agent, contributing to drug discovery efforts.
- Phthalazin Derivative: Phthalazin derivatives are known for various pharmacological properties, including anticancer and anti-inflammatory activities, making this compound a candidate for further research in medicinal chemistry.
- Fluorinated Compounds: The incorporation of fluorine in organic molecules often improves their biological efficacy. Researchers are keen to explore these features to develop therapeutic agents.
- Environmentally Friendly Chemistry: The synthesis of such compounds emphasizes the shift towards developing eco-friendly methods in chemical manufacturing, reducing solvent use and waste generation.
As research continues, compounds like 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid could lead to breakthroughs in effective treatments for various health conditions. The exploration of their mechanisms of action can unveil new pathways in drug development.
In the words of a renowned chemist, "Every compound has a story, and with each discovery, we turn a new page." This compound certainly holds the potential to add valuable chapters to the narrative of medicinal chemistry.
Synonyms
ZOPOLRESTAT
110703-94-1
Alond
CP-73850
CP 73850
Zopolrestatum
Zopolrestatum [INN-Latin]
Xedia
2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid
3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid
1PV3S9WP3D
Zopolrestat [USAN:INN:BAN]
Alond (TN)
CP-73,850
ZOPOLRESTAT [MI]
1-Phthalazineaceticacid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-
ZOPOLRESTAT [INN]
ZOPOLRESTAT [USAN]
ZOPOLRESTAT [WHO-DD]
CHEMBL10372
DTXSID80149365
1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-
3,4-Dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazineacetic acid
3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid
Zopolrestatum (INN-Latin)
(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid
2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrophthalazin-1-yl)acetic acid
1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-
ZST
UNII-1PV3S9WP3D
4kyh
2-(4-oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)phthalazin-1-yl)acetic acid
MFCD00865476
Zopolrestat (USAN/INN)
3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazine-acetic acid
SCHEMBL49012
MLS006010619
GTPL7419
DTXCID3071856
BDBM16452
Zopolrestat, >=98% (HPLC)
AKOS040754579
DB08772
DA-72363
HY-19687
MS-27339
SMR002529706
CS-0016207
NS00068308
C01865
D02328
G12704
BRD-K47710001-001-01-1
Q27089300
[4-oxo-(5-trifluoromethyl-benzothiazol-2-ylmethyl)-3,4-dihydro-phthalazin-1-yl]-acetic acid
3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-phthalazin-1-ylacetic acid
2-(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid
682-922-9
Solubility Profile of 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid
The solubility of 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid (C20H12F3N3O3S) can be influenced by various factors due to its complex structure. Here are some key points to consider:
In summary, while 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid can be expected to show moderate solubility in polar solvents due to its structural features, specific solubility data should be determined experimentally for accurate applications.